You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CPD

Patient With Shortness of Breath and Fever: A Practical Approach to Treatment Optimization in COPD

  • Authors: Daiana Stolz, MD, PhD
  • CPD Released: 5/17/2022
  • Valid for credit through: 5/17/2023
Start Activity

  • Credits Available

    Non-US Physicians - maximum of 1.00 CPD

    You Are Eligible For

    • Letter of Completion

Target Audience and Goal Statement

This educational activity is intended for an international audience of non-US physicians, specifically primary care physicians and pulmonologists.

The goal of this activity is that learners will be better able to improve early recognition of exacerbations of chronic obstructive pulmonary disease (COPD) and optimize therapy with the goal of improving patient outcomes.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Impact of exacerbations on patients with COPD
    • Evidence from clinical trials for efficacy and safety of triple bronchodilation therapy in patients with COPD
  • Have greater competence related to
    • Assessment for COPD exacerbation 
    • Pharmacologic management for prevention of COPD exacerbation 


Disclosures

WebMD Global requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships with ineligible companies.


Faculty

  • Daiana Stolz, MD, PhD

    Professor of Respiratory Medicine
    University Hospital
    Basel, Switzerland

    Disclosures

    Disclosure: Daiana Stolz, MD, PhD, has the following relevant financial relationships:
    Consultant or advisor for: Merck Sharp & Dohme Corp
    Speaker or member of speakers bureau for: AstraZeneca AG; GlaxoSmithKline AG; Novartis AG; Pfizer; Schwabe Pharma AG; Zambon
    Research funding from: AstraZeneca AG; Boston Scientific AG; Curetis AG; Circassia Pharmaceuticals

Editors

  • Gillian Griffith, BA (Mod), MA

    Medical Education Director, WebMD Global, LLC

    Disclosures

    Disclosure: Gillian Griffith, BA (Mod), MA, has no relevant financial relationships.

  • Christina T. Loguidice, BA

    Medical Education Director, Medscape, LLC

    Disclosures

    Disclosure: Christina T. Loguidice, BA, has no relevant financial relationships.

Compliance Reviewer

  • Susan L. Smith, MN, PhD

    Associate Director, Accreditation and Compliance

    Disclosures

    Disclosure: Susan L. Smith, MN, PhD, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.


Accreditation Statements

    For Physicians

  • The Faculty of Pharmaceutical Medicine of the Royal Colleges of Physicians of the United Kingdom (FPM) has reviewed and approved the content of this educational activity and allocated it 1.0 continuing professional development credits (CPD).

    Contact WebMD Global

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information about your eligibility to claim credit, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent participating in the activity. To successfully earn credit, participants must complete the activity online during the credit eligibility period that is noted on the title page.

Follow these steps to claim a credit certificate for completing this activity:

  1. Read the information provided on the title page regarding the target audience, learning objectives, and author disclosures, read and study the activity content and then complete the post-test questions. If you earn a passing score on the post-test and we have determined based on your registration profile that you may be eligible to claim CPD credit for completing this activity, we will issue you a CPD credit certificate.
  2. Once your CPD credit certificate has been issued, you may view and print the certificate from your CME/CE Tracker. CPD credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates by accessing "Edit Your Profile" at the top of the Medscape Education homepage.

We encourage you to complete an Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates by accessing "Edit Your Profile" at the top of your Medscape homepage.

*The credit that you receive is based on your user profile.

CPD

Patient With Shortness of Breath and Fever: A Practical Approach to Treatment Optimization in COPD

Authors: Daiana Stolz, MD, PhDFaculty and Disclosures

CPD Released: 5/17/2022

Valid for credit through: 5/17/2023

processing....

The following cases are modeled on the interactive grand rounds approach. The questions within the activity are designed to test your current knowledge. After each question, you will be able to see whether you answered correctly and read evidence-based information that supports the most appropriate answer choice. The questions are designed to challenge you; you will not be penalized for answering the questions incorrectly. At the end of the activity, there will be a short post-test assessment based on the material presented.

CASE PART 1: PATIENT HISTORY AND PRESENTATION

Martina is an overweight 55-year-old woman who presents to her family medicine office for a routine visit, during which she reports some dyspnea (ie, shortness of breath). She mentions that she has had a mild cough for some time, which is worse in the morning and sometimes produces grey sputum. She never required antibiotics or oral steroids.

Martina partially attributes her symptoms to her work at a hair salon as a stylist and colorist. She says her salon has poor ventilation and some of her coworkers smoke. Martina has a 30-pack-per-year history of smoking, which she stopped several years earlier after she developed trouble climbing the 3 flights of stairs to get to her apartment. She lives with her husband and 16-year-old son, neither of whom smoke. Martina confirms that her only comorbid condition is arterial hypertension but says there is a history of asthma in her family. Martina’s medical history includes chronic obstructive pulmonary disease (COPD), which is being treated with a long-acting muscarinic antagonist (LAMA), and hypertension, which is well controlled with an angiotensin-converting enzyme (ACE) inhibitor. She says she does not have any allergies.

  • Print